[Reimbursement for   blockaders in angina pectoris].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics
Refusion for -blokkere ved angina pectoris.